News Daily News Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk Leah Lawrence August 03, 2017
Presentation LAA 2017 Warfarin and NOACs in Non-Valvular Atrial Fibrillation Presenter: Gregg W. Stone July 21, 2017
News Daily News Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results Todd Neale July 14, 2017
News Daily News Early Cardiology Care Tied to Better Outcomes for New A-fib Patients Todd Neale June 26, 2017
News Daily News Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD Yael L. Maxwell June 20, 2017
News Daily News Apixaban Recalled Following Complaints of Dose-Packaging Mismatch Shelley Wood June 13, 2017
News Conference News EuroPCR 2017 EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure Michael O'Riordan May 24, 2017
News Daily News ‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry Todd Neale May 17, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing Todd Neale April 26, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Daily News MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke Michael O'Riordan April 05, 2017
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Conference News ACC 2017 RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest Yael L. Maxwell March 20, 2017
News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017